Sc China Holding LTD Lyell Immunopharma, Inc. Transaction History
Sc China Holding LTD
- $2.79 Billion
- Q2 2024
A detailed history of Sc China Holding LTD transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Sc China Holding LTD holds 3,045,997 shares of LYEL stock, worth $2.92 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
3,045,997
Previous 3,045,997
-0.0%
Holding current value
$2.92 Million
Previous $6.79 Million
34.98%
% of portfolio
0.16%
Previous 0.72%
Shares
2 transactions
Others Institutions Holding LYEL
# of Institutions
119Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$19.4 Million31.93% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$14.5 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$14.5 Million16.63% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$12.9 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $238M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...